Results 21 to 30 of about 3,177,071 (215)

Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases. [PDF]

Cochrane Database Syst Rev
BACKGROUND Psychedelic-assisted therapy refers to a group of therapeutic practices involving psychedelics taken under therapeutic supervision from physicians, psychologists, and others.
Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C.   +7 more
europepmc   +2 more sources

A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy

General Hospital Psychiatry
BACKGROUND Psilocybin-assisted therapy (PAT) has shown promising effects in treating depressive symptoms, but the role of the therapeutic component remains unclear.
Jennie Hultgren, Matthias H Hafsteinsson, Joel Gruneau Brulin   +2 more
exaly   +2 more sources

The ethical use of therapeutic touch in psychedelic-assisted therapy: a qualitative study of researcher perspectives and experiences. [PDF]

Ther Adv Psychopharmacol
Background: Physical touch is often included as a supportive or therapeutic tool in psychedelic-assisted therapy (PAT), involving instrumental forms of physical contact, supportive touch and somatic techniques.
McHerron D, Barber M, Ham R, Liknaitzky P, Carter A, Gardner J.   +5 more
europepmc   +2 more sources

Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment. [PDF]

Med Sci Monit
Psychedelics, derived from the Greek words “psyche” (soul) and “deloun” (revealing), are substances historically and currently considered “soul-revealing”.
Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A.   +6 more
europepmc   +2 more sources

Not a Standalone Treatment: Considerations for Psychedelic‐Assisted Therapy [PDF]

Brain and Behavior
Purpose Psychedelic‐assisted therapy (PAT) is becoming a clinically available treatment for patients with treatment‐resistant conditions such as depression and post‐traumatic stress disorder (PTSD) in several countries.
Sharon Murphy, Elizabeth Stewart, Jacqueline Winship, Laura Kampel, Benjamin Stiel, Justine Ellis   +5 more
doaj   +2 more sources

Digital Enablement of Psychedelic-Assisted Therapy in Non-Clinical Settings: A Systematic Review of Safety, Efficacy, and Implementation Models

Psychoactives
Psychedelic-assisted therapy offers rapid and profound benefits for treatment-resistant psychiatric conditions but remains constrained by the need for intensive, clinic-based administration.
Brendan Driscoll, Shaheen E. Lakhan
doaj   +2 more sources

A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care. [PDF]

J Hosp Palliat Nurs
Psychedelic-assisted therapy (PAT) involves supported experiences with psychedelic medicines in carefully curated environments. Early evidence suggests possible utility of PAT for addressing psychosocial-spiritual-existential concerns, yet gaps remain in
Megan Miller, Molly Meyers, Annona Martin, Stephanie Napolitano, Caroline Dorsen, Andrew D. Penn, William E. Rosa   +6 more
europepmc   +2 more sources

Qualitative Analysis of Views of Psychedelic-Assisted Therapy in Low-Income, Urban, Black Americans. [PDF]

Psychedelic Med (New Rochelle)
Introduction: Black Americans are significantly underrepresented in psychedelic trials despite significant mental health disparities. Growing research suggests that psychedelic-assisted therapy (PAT) is an effective treatment for post-traumatic stress ...
Carter S, Packard G, Maples-Keller JL.
europepmc   +2 more sources

Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.

JAMA Netw Open
Key Points Question Is the quantity of psychological therapy associated with symptom reduction in psychedelic-assisted therapy (PAT) for depressive symptoms?
Florineth GA, Klima I, Boeker AL, Catzeflis P, Wopfner A, Denier N, Bracht T, Adorjan K, Pfammatter M, Müller F, Soravia LM.   +10 more
europepmc   +2 more sources

Oncology Providers' Perspectives on Psychedelic-Assisted Therapy. [PDF]

Am J Hosp Palliat Care
Purpose Despite most psychedelic substances remaining Schedule I, clinical research exploring psychedelic-assisted therapy (PAT) in oncology is expanding.
Hanubal KS, Munjal AN, Park J, Banks R, Choi E, Hoyt MA, Humphreys JN, Mojtahedzadeh M, Harris JP.   +8 more
europepmc   +2 more sources